Profile cover photo
Profile photo
TriLink BioTechnologies
23 followers -
TriLink manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets. TriLink holds the patent on a unique Hot Start PCR solution, CleanAmp™. They operate a quality system based on the FDA’s QSR 21 CFR 820 and the ISO 9001:2008 standard, and practice continual improvement. Since 1996, TriLink's solutions have helped advance drug discovery and biomedical research. Specialties Oligonucleotide Synthesis, Modified Nucleoside Triphosphates, RNA Transcription (Long RNA & mRNA), CleanAmp Hot Start PCR Products, Custom Chemistry
TriLink manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets. TriLink holds the patent on a unique Hot Start PCR solution, CleanAmp™. They operate a quality system based on the FDA’s QSR 21 CFR 820 and the ISO 9001:2008 standard, and practice continual improvement. Since 1996, TriLink's solutions have helped advance drug discovery and biomedical research. Specialties Oligonucleotide Synthesis, Modified Nucleoside Triphosphates, RNA Transcription (Long RNA & mRNA), CleanAmp Hot Start PCR Products, Custom Chemistry

23 followers
About
TriLink BioTechnologies's posts

Post has attachment
CRISPR can be used for genome-wide identification of functional long non-coding RNA (lncRNA) in human cells. Let's explore more in the latest 'Zone in With Zon' blog post on #CRISPR.


Post has attachment
LOC-enabled devices can be portable, driven by remote control, or flown-“in-and-out” for important POC situations needing nucleic acid-based tests. Let's explore more in the latest 'Zone in With Zon' blog post on #Diagnostics.

http://bit.ly/2kOXUFi
Photo

Post has attachment
"The general approach taken to demonstrate proof-of-concept for mass-tagged nanopore DNA Seq-by-Syn is depicted below in simplified cartoon form, but involves a true tour de force—in my opinion—of three key technologies." - Jerry Zon. Let's explore more in the latest 'Zone in with Zon' blog post on #Sequencing

http://bit.ly/2kebXkW
Photo

Jerry's talking Top 10 Innovations of 2016 on our latest 'Zone in with Zon' blog post: http://bit.ly/2jeZGfM

Post has attachment
Nanobombs for light-activated microRNA drug delivery? Let's explore more in the latest 'Zone in with Zon' blog post on #microRNA http://bit.ly/2hQa2m3
Photo

Post has attachment
The growing number of infections by a formerly obscure but deadly fungus is frightening. This so-called “superbug” is an antibiotic-resistant fungus called Candida auris (C. auris) that’s worth knowing about. Let's explore more in the latest 'Zone in with Zon' blog post on #fungus.

http://bit.ly/2h2YxJQ
Photo

Our collective understanding of RNA and DNA is limited, in part, by the analytical tools we use for these nucleic acid molecules. Let's explore more in the latest 'Zone in with Zon' blog post on #Epigenetics

http://bit.ly/2ghb8qf

Post has attachment
Just when you thought that the “CRISPR craze” would soon transition from the fundamental discovery phase to the improvements phase, something entirely new for CRISPR has come along. That something, recently published by Feng Zhang and others in venerable Science magazine, targets RNA instead of DNA. Let's explore more in the latest 'Zone in with Zon' blog post on #CRISPR

http://bit.ly/2fzAeCs
Photo

Post has attachment
The 12th Annual OTS Meeting in Montreal brought up an RNAi approach to treating Preeclampsia, an Ionis Video for Spinal Muscular Atrophy and 30 years later, PS-Modified Oligonucleotides continue to be Enabling! Let's explore more from the OTS Meeting in the latest 'Zone in with Zon' blog post on #Antisense

http://bit.ly/2fcmMop
Photo

Post has attachment
Chinese researchers are poised for the first human clinical trial using CRISPR, and an analogous study in the US awaiting FDA approval. Both of these trials involve forms of cancer immunotherapy. Let's explore more in the latest 'Zone in with Zon' blog post on #GeneEditing

http://bit.ly/2dYHCno
Wait while more posts are being loaded